文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

比较基于二甲基二十八烷基溴化铵(DDA)、3β-[N-(N',N'-二甲氨基乙烷)羰基]胆固醇(DC-Chol)和 1,2-二油酰基-3-三甲铵丙烷(DOTAP)的脂质体的储存库效应和免疫原性:延长脂质体的保留时间可介导更强的 Th1 反应。

Comparison of the depot effect and immunogenicity of liposomes based on dimethyldioctadecylammonium (DDA), 3β-[N-(N',N'-Dimethylaminoethane)carbomyl] cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium propane (DOTAP): prolonged liposome retention mediates stronger Th1 responses.

机构信息

School of Life and Health Sciences, Aston University, Birmingham, UK.

出版信息

Mol Pharm. 2011 Feb 7;8(1):153-61. doi: 10.1021/mp100208f. Epub 2010 Dec 15.


DOI:10.1021/mp100208f
PMID:21117621
Abstract

The immunostimulatory capacities of cationic liposomes are well-documented and are attributed both to inherent immunogenicity of the cationic lipid and more physical capacities such as the formation of antigen depots and antigen delivery. Very few studies have however been conducted comparing the immunostimulatory capacities of different cationic lipids. In the present study we therefore chose to investigate three of the most well-known cationic liposome-forming lipids as potential adjuvants for protein subunit vaccines. The ability of 3β-[N-(N',N'-dimethylaminoethane)carbomyl] cholesterol (DC-Chol), 1,2-dioleoyl-3-trimethylammonium propane (DOTAP), and dimethyldioctadecylammonium (DDA) liposomes incorporating immunomodulating trehalose dibehenate (TDB) to form an antigen depot at the site of injection (SOI) and to induce immunological recall responses against coadministered tuberculosis vaccine antigen Ag85B-ESAT-6 are reported. Furthermore, physical characterization of the liposomes is presented. Our results suggest that liposome composition plays an important role in vaccine retention at the SOI and the ability to enable the immune system to induce a vaccine specific recall response. While all three cationic liposomes facilitated increased antigen presentation by antigen presenting cells, the monocyte infiltration to the SOI and the production of IFN-γ upon antigen recall was markedly higher for DDA and DC-Chol based liposomes which exhibited a longer retention profile at the SOI. A long-term retention and slow release of liposome and vaccine antigen from the injection site hence appears to favor a stronger Th1 immune response.

摘要

阳离子脂质体的免疫刺激能力已有充分的文献记载,这既归因于阳离子脂质的固有免疫原性,也归因于其更物理的能力,如抗原库的形成和抗原递呈。然而,很少有研究比较不同阳离子脂质的免疫刺激能力。在本研究中,我们因此选择了三种最著名的阳离子脂质体形成脂质作为蛋白质亚单位疫苗的潜在佐剂进行研究。3β-[N-(N',N'-二甲氨基乙酰胺)碳酰基]胆固醇(DC-Chol)、1,2-二油酰基-3-三甲铵丙烷(DOTAP)和二甲基十八烷基铵(DDA)脂质体结合免疫调节海藻糖二硬脂酸酯(TDB)在注射部位(SOI)形成抗原库并诱导针对共给药结核疫苗抗原 Ag85B-ESAT-6 的免疫回忆反应的能力报告。此外,还介绍了脂质体的物理特性。我们的结果表明,脂质体组成在疫苗在 SOI 的保留和使免疫系统能够诱导疫苗特异性回忆反应的能力方面起着重要作用。虽然所有三种阳离子脂质体都促进了抗原呈递细胞对抗原的呈递,但单核细胞向 SOI 的浸润和抗原回忆时 IFN-γ 的产生在基于 DDA 和 DC-Chol 的脂质体中明显更高,它们在 SOI 中的保留时间更长。从注射部位缓慢释放脂质体和疫苗抗原的长期保留似乎有利于更强的 Th1 免疫反应。

相似文献

[1]
Comparison of the depot effect and immunogenicity of liposomes based on dimethyldioctadecylammonium (DDA), 3β-[N-(N',N'-Dimethylaminoethane)carbomyl] cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium propane (DOTAP): prolonged liposome retention mediates stronger Th1 responses.

Mol Pharm. 2010-12-15

[2]
Cationic DDA/TDB liposome as a mucosal vaccine adjuvant for uptake by dendritic cells in vitro induces potent humoural immunity.

Artif Cells Nanomed Biotechnol. 2018-2-15

[3]
Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.

BMC Res Notes. 2017-1-26

[4]
Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice.

PLoS One. 2015-10-6

[5]
PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution.

J Control Release. 2011-12-29

[6]
Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice.

Int Immunopharmacol. 2018-6-23

[7]
Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen.

J Control Release. 2009-10-26

[8]
Pegylation of DDA:TDB liposomal adjuvants reduces the vaccine depot effect and alters the Th1/Th2 immune responses.

J Control Release. 2011-10-18

[9]
Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl-sn-glycero-3-phosphocholine content in liposomal adjuvants.

J Pharm Pharmacol. 2013-11-19

[10]
Lipid conjugation of TLR7 agonist Resiquimod ensures co-delivery with the liposomal Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation compared to non-conjugated Resiquimod+CAF01.

J Control Release. 2018-10-3

引用本文的文献

[1]
Simultaneous enhancement of cellular and humoral immunity by the lymph node-targeted cholesterolized TLR7 agonist liposomes.

Acta Pharm Sin B. 2024-10

[2]
Lipid Nanoparticle with 1,2-Di-O-octadecenyl-3-trimethylammonium-propane as a Component Lipid Confers Potent Responses of Th1 Cells and Antibody against Vaccine Antigen.

ACS Nano. 2024-7-2

[3]
Tailoring T profiles enhances antibody persistence to a clade C HIV-1 vaccine in rhesus macaques.

Elife. 2024-2-22

[4]
Nanotechnology Platform for Advancing Vaccine Development against the COVID-19 Virus.

Diseases. 2023-12-10

[5]
Advances in saRNA Vaccine Research against Emerging/Re-Emerging Viruses.

Vaccines (Basel). 2023-6-24

[6]
A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG.

NPJ Vaccines. 2023-5-9

[7]
An Insight into Advances in Developing Nanotechnology Based Therapeutics, Drug Delivery, Diagnostics and Vaccines: Multidimensional Applications in Tuberculosis Disease Management.

Pharmaceuticals (Basel). 2023-4-12

[8]
Development of a rapid in vitro pre-screen for distinguishing effective liposome-adjuvant delivery systems.

Sci Rep. 2022-7-20

[9]
Optimization of Lipid Nanoformulations for Effective mRNA Delivery.

Int J Nanomedicine. 2022

[10]
MUC1 Specific Immune Responses Enhanced by Coadministration of Liposomal DDA/MPLA and Lipoglycopeptide.

Front Chem. 2022-2-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索